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Purpose: Marked extracellular matrix (ECM) remodeling occurs in the human optic nerve head in primary open angle
glaucoma (POAG). The glial fibrillary acid protein (GFAP) negative lamina cribrosa cell may play an important role in
this remodeling process. We report the first study of global and ECM-focused gene transcription differentials between
GFAP-negative lamina cribrosa (LC) cells from normal and POAG human donors.
Methods: GFAP-negative LC cell lines were generated from the optic nerve tissue of four normal (n=4) and four POAG
(n=4) human donors. Using Affymetrix U133A arrays the transcriptional profile between the normal and diseased groups
were compared. Bioinformatic analysis was performed using robust multichip average (RMA Express) and EASE/David.
Real time TaqMan PCR and immunohistochemistry analyses were performed to validate the microarray data.
Results: 183 genes were upregulated by greater than 1.5 fold and 220 were down regulated by greater than 1.5 fold in the
POAG LC cells versus normal controls. Upregulated genes in POAG LC cells included, transforming growth factor beta
1 (TGFβ1), secreted acid protein cysteine rich (SPARC), periostin (POSTN), thrombospondin-1 (THBS1), cartilage linking
protein-1 (CRTL-1), and collagen type I (COL1A1), collagen type V (COL5A1), and collagen type XI (COL11A1).
Downregulated ECM genes in POAG included fibulin 1 (FBLN1), decorin (DCN), and collagen type XVIII (COL18A1).
All TaqMan PCR validation assays were significant (*p<0.05) and consistent with the array data. Immunohistochemistry
of one target (periostin) confirmed its differential expression at the protein level in POAG optic nerve head tissue compared
with non-glaucomatous controls. Functional annotation and over-representation analysis identified ECM genes as a
statistically over-represented class of genes in POAG LC cells compared with normal LC cells.
Conclusions: This study reports for the first time that POAG LC cells in-vitro demonstrate upregulated ECM and pro-
fibrotic gene expression compared with normal LC cells. This may be a pathological characteristic of this cell type in
POAG in-vivo. We believe that the LC cell may be a pivotal regulator of optic nerve head ECM remodeling in POAG
and an attractive target for molecular therapeutic strategies in the future.
Primary  open  angle  glaucoma  (POAG)  is  a  sight
threatening progressive optic neuropathy affecting 60 million
people world wide [1]. Raised intraocular pressure (IOP) and
reduced optic nerve head vascular perfusion are proposed risk
factors for the development of this disorder [2,3]. One of the
key  pathological  characteristics  of  POAG  is  fibrotic
extracellular matrix (ECM) remodeling of the optic nerve
head  [4].  These  ultrastructural  changes  include  increased
deposition of the proteins collagen I, IV and VI in addition to
the synthesis of dysfunctional forms of elastin fiber [5]. This
disturbed  ECM  metabolism  is  particularly  obvious  in  the
lamina cribrosa layer, where it is suspected of undermining
the overall structural integrity of the optic nerve head (ONH)
[6].  Mathematical  models  predict  that  chronically  raised
intraocular pressure above 30 mmHg will markedly compress
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the lamina cribrosa which may account for the characteristic
'cupped'  morphology  of  the  glaucomatous  ONH  [7].
Similarly,  in-vivo  primate  models  of  POAG  confirm  this
compression of the lamina cribrosa with consequent arrest of
axoplasmic flow within its constituent retinal ganglion cell
axons [8].
While  the  existence  of  ECM  remodeling  in  the
glaucomatous ONH is well documented, other aspects of the
relevant molecular mechanism are still under study. A major
area  of  interest  centers  on  identifying  the  cell  (or  cells)
responsible for producing this aberrant lamina cribrosa ECM
[9]. One member of the glial cell population of the ONH that
is emerging as a likely candidate is the GFAP-negative lamina
cribrosa (LC) cell [10]. The LC cell is of relevance here
because it bears similarities to myofibroblastic cells known to
be responsible for fibrotic disease development elsewhere in
the human body [11]. These similarities include constitutive
expression  of  alpha-SMA,  elastin,  collagen  type  I,  and
fibronectin [12]. In addition, we have previously shown that
the  LC  cell's  capacity  for  TGF-β  driven  release  of  major
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76modulators of fibrosis such as connective tissue growth factor
(CTGF) and platelet derived growth factor-alpha (PDFG-
alpha), points to a potentially pivotal role for this cell type in
generalized wound healing in the ONH [13].
Other lines of enquiry have focused on the triggers for
cellular release of fibrotic tissue and remodelling enzymes in
the lamina cribrosa in POAG. In addition to molecular stimuli
such as TGF- β, important roles for mechanical strain and
hypoxia have been proposed in this context [14,15]. However,
significant interplay between these diverse stimuli is a likely
imperative in dictating the final glaucomatous phenotype. In
probing the global gene expression changes in POAG LC cells
we intended to search for genes concerned with fibrotic ECM
changes but also others relevant to a more global pathological
mechanism  of  POAG  where  neurodegeneration,  hypoxic
stress and cellular mechanical resilience may play a role. In
this study, microarray analysis was used to define for the first
time, a baseline global and ECM gene expression differential
between POAG and normal LC cells. In so doing, a panel of
established and potentially novel modulators of glaucomatous
optic nerve head molecular pathology were identified.
METHODS
In-vitro lamina cribrosa (LC) cell culture: Twelve primary
GFAP-negative  lamina  cribrosa  (LC)  cell  lines  were
generated from human optic nerve head explants as described
previously  and  supplied  by  Alcon  Research  Labs  at  Fort
Worth, TX [12]. Six normal LC cell lines were from four
donors with no history of eye disease and six POAG LC cell
lines were from four donors with a documented history of
POAG (Figure 1A,B). Cultures were maintained in DMEM
(Sigma, Dorset, UK) supplemented with 10% fetal calf serum,
penicillin  (100  U/ml)  and  streptomycin  (100  μg/ml)  in  a
humidified incubator containing 5% CO2/95% air at 37 °C.
All cells maintained their broad polygonal morphology during
propagation in vitro and were used between passages 4 and 6.
The normal LC cells and POAG LC cells were cultured until
approximately 90% confluent on 100 mm (p100) plates. The
cells were then serum starved for 24 h before being harvested
for extraction of total cellular RNA.
Oligonucleotide microarray analysis: RNA isolation, cDNA
synthesis, in vitro transcription and microarray analysis were
performed as described previously [16]. Briefly, total RNA
was isolated from all LC cells using the RNeasy minicolumn
protocol  (Qiagen,  Valencia,  CA).  cDNA  was  synthesized
from total RNA using SuperScript Choice Kit (Invitrogen,
Paisley,  UK).  Biotin  labeled  cRNA  was  prepared  from
template cDNA followed by fragmentation and hybridization
to  Affymetrix  HG-U133A  arrays  as  per  the  Affymetrix
protocol (Affymetrix, Santa Clara, CA). Arrays were then
washed  and  fluorescently  labeled  before  scanning  with  a
confocal laser (Affymetrix, CA). Two separate microarray
analyses (n=2) using separate human donors were performed
for this study. The microarray experimental study design is
illustrated in Figure 1. For microarray analysis 1 (Figure 1A),
RNA from three separate normal and three separate POAG
donors  were  pooled  to  one  'normal'  and  one  'POAG'
microarray respectively. For microarray analysis 2 (Figure
1B), RNA from a fourth normal donor was pooled to a second
‘normal’ micorarray and RNA from a fourth POAG donor was
pooled  to  a  second  ‘POAG’  microarray.  A  total  of  four
microarrays were used (two normal and two POAG).
Image files were obtained through Affymetrix MAS 5.0
software.  Array  normalization  and  pre-processing  was
performed using Robust multichip average (RMA) to allow
global comparison of all four LC cell microarrays. RMA is a
function within R statistical software that analyses directly
from the Affymetrix microarray *.cel image file [17]. R v2.2
running on Macintosh v10.4 operating system was used with
the installed component packages Affy v1.8.1, Tools v2.2 and
Biobase v1.8. RMA consists of several steps to background
adjust, quantile normalize, log transform and summarize the
gene expression values. Background adjustment compensates
for non-specific cRNA/probe binding. The average of the
lowest 2% of probe cell values in a region of the microarray
is taken as the background value for that region and subtracted
from all values in that region. There were 16 such regions on
each  HG-U133A  microarray  used.  Quantile  normalization
unifies perfect match cRNA/target probe distributions across
the  arrays.  This  minimises  the  effects  of  variation  in  the
amounts  of  RNA  used,  the  rates  of  the  microarray
hybridization reactions and the conditions of hybridization
within  the  Affymetrix  hybridization  oven.  The  final  step,
summarization, median polishes the Log Base2 transformed
probe  signal  level  data.  Output  from  this  analysis  was
exported in a *.csv file format and filtered using Microsoft
Excel. Probe sets with low level expression intensities of less
than  6.5  were  removed  from  the  microarrays  and  the
remaining  highly  expressed  probe  set  values  in  both  the
normal LC cell and POAG LC cell arrays were subtracted to
calculate a signal log ratio (SLR). Genes with SLRs greater
than +0.5 or less than −0.5 (±1.5 fold change) were taken to
identify the reliably differentially expressed genes between
normal and POAG LC cells [18].
Bioinformatic analysis of microarray data: The filtered group
of genes with signal log ratios (SLR) of greater than +0.5 or
less than −0.5 were annotated and arranged into biologically
relevant  categories  using  NIH  EASE  software.  The  NIH
Expression Analysis and Systematic Explorer (EASE) can
identify themes of gene expression within a data set [19]. More
precisely EASE uses a variation of the Fisher exact probability
(EASE score) to rank functional gene clusters by statistical
over-representation  (overexpression)  by  examining  the
number of individual genes in specific categories relative to
all the genes in the same category available for assay on the
HG-U133A  microarray.  EASE  converts  Affymetrix  probe
IDs  to  LocusLink  numbers,  ensuring  that  a  single  gene
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77represented by more than one identifier (as may occur in
GenBank) receives only one vote for each of its ontological
categories. The statistically overexpressed gene categories in
POAG LC cells versus normal LC cells were separated into
three broad components of (1) biologic process (2) molecular
function, and (3) cellular component.
Quantitative real-time PCR validation of microarray data:
The normal versus POAG LC cell array data was validated as
follows. Total RNA (3 μg) was used from three normal (n=3)
and three POAG (n=3) LC cell lines to synthesize first-strand
cDNA using random hexamers and SuperScript II reverse
transcriptase  (Invitrogen,  Paisley,  UK).  The  experimental
design for these assays is illustrated in Figure 2. The six cDNA
samples  (n=3  normal,  n=3  POAG)  were  used  for  six
individual quantitative real-time PCR amplification assays for
9  gene  targets  with  TaqManTM  chemistry  (Applied
Biosystems,  Foster  City,  CA;  Figure  2).  The  fluorogenic
probe  and  sequence  specific  primers  for  cartilage  linking
protein 1 (CRTL-1), sulfatase 1 (SULF1), bone morphogenetic
protein-1  (BMP-1),  dystrophin  (DMD),  thrombospondin  1
(THBS1),  periostin  (POSTN),  neuritin  1  (NRN1),  and
prostaglandin D2 synthase (PTGDS) with the endogenous
Figure  1.  Microarray  assay
experimental  design.  For  microarray
analysis 1 (A), RNA from three separate
normal (n=3) and three separate POAG
(n=3) donor LC cell lines were pooled
to  individual  'normal'  and  'POAG'
microarrays respectively. In microarray
analysis 1 LC cells from the normal and
POAG donors were passaged in a 1:1
ratio. For microarray analysis 2 (B) a
fourth normal and a fourth POAG donor
provided RNA which was pooled to a
second ‘normal’ and a second ‘POAG’
microarray respectively. In microarray
analysis 2 LC cells from the normal and
POAG donors were passaged in a 1:3
ratio.  All  four  arrays  were  then
normalized  together  and  compared
using  Robust  Multichip  Average
(RMA)  software.  The  LC  cells  used
were at passages 5 and 6. NLC=normal
lamina  cribrosa,  GLC=POAG  lamina
cribrosa.
Molecular Vision 2009; 15:76-88 <http://www.molvis.org/molvis/v15/a8> © 2009 Molecular Vision
78control  18S  rRNA  were  designed  and  optimized  as  pre-
formulated  assay  reagents  (Assay-on-Demand,  Applied
Biosystems).  Duplicate  cDNA  template  samples  were
amplified  and  analyzed  in  the  Prism  7900HT  sequence
detection  system  (Applied  Biosystems).  Thermal  cycler
conditions were 10 min at 95 °C followed by 40 cycles of 30
s at 95 °C to denature the DNA and 30 s at 60 °C to anneal
and extend the template. A standard curve of cycle thresholds
using serial dilutions of cDNA samples were established and
used to calculate the relative abundance of the 9 target genes
between normal LC cell and POAG LC cell samples. Values
were normalized to the relative amounts of 18S mRNA, which
were obtained from a similar standard curve.
Immunoflourescence histochemistry: Eyes from three human
donors were obtained from regional eye banks and placed in
4% neutral buffered formalin within 4 h of death. Two of the
donors  had  a  documented  history  of  glaucoma.  The  third
donor had no history of ocular disease (normal control). The
posterior segments were embedded in paraffin and 6 μm optic
nerve head sections were cut and mounted on glass slides.
After paraffin removal, the tissue was quenched for aldehydes
by treatment in a 0.05 M glycine (Sigma, Dorset, UK) solution
for 15 min. Nonspecific binding sites were then blocked for
15  min  with  phosphate  buffered  saline  (PBS)  solution
containing 1% BSA and 1% serum from the species (rabbit)
in which the secondary antibody was raised. The slides were
washed in PBS before incubation with a mixture of anti-
Periostin antibody (diluted 1:25 in PBS; Abcam, Cambridge,
MA) at 4 °C overnight. The sections were then washed 3 times
in PBS. For the detection of periostin (POSTN), the sections
were incubated with Alexa Fluor-488 labeled anti-rabbit IgG
for 1 h at room temperature (RT) (secondary antibody was
obtained from Molecular Probes, Leiden, The Netherlands).
The tissue nuclei were then DAPI stained (300 nM in water)
for 5–10 min. Images were captured with a Nikon Microphot
FXA (Nikon, Inc., Melville, NY) equipped with a SenSys
CCD  camera  (Photometrics,  Tucson,  AZ).  Images  were
deconvoluted using Scanalytics IPLAB (Scanalytics, Fairfax,
VA) and Vaytek Microtome (Vaytek, Fairfield, IA) software.
Statistical analysis: Data from real time PCR assays were
summarized as the mean from three separate experiments
(n=3).  The  paired  student  t-test  was  used  to  analyze  the
statistical significance (*p<0.05) of differences between mean
values.
RESULTS
Global and ECM transcription differential between POAG
and normal LC cells: The pair-wise comparison of RMA
normalized  expression  values  for  all  22,283  mRNA
transcripts  assayed  in  the  two  normal  and  two  POAG
microarrays are shown in Figure 3. Microarray analysis 1 is
shown in Figure 3A and microarray analysis 2 is shown in
Figure 3B. 183 transcripts were upregulated by >+0.5 SLR
and 220 were down regulated by <−0.5 SLR in the POAG LC
cell  transcriptome  versus  the  normal.  In  each  gene
comparison, at least one of the probesets had an RMA signal
intensity greater than or equal to 6.5. These data are freely
available  for  download  at  the  Gene  Expression  Omnibus
(GEO)  database  accessions  (GSE13534).  Appendix  1
summarize  the  pattern  of  change  within  the  major  gene
categories  classified  on  the  basis  of  known  function  and
statistically  significant  over  representation.  Among  the
functional  categories  most  significantly  expressed  were
extracellular matrtix (ECM) (EASE score <0.0001), collagen
(EASE score <0.05), and extracellular space (EASE score
<0.05).
Table  1  highlights  50  (25  upregulated  and  25  down
regulated) of the genes whose mRNA levels differed most
between POAG and normal LC cells. Among the 25 most
upregulated  genes  in  POAG  LC  cells  were  periostin
Figure  2.  PCR  validation  assay
experimental design. Total RNA (3 μg)
was used from three normal and three
POAG LC cell lines to synthesize first-
strand cDNA. The six cDNA samples
(n=3 normal, n=3 POAG) were used for
six  individual  quantitative  real-time
PCR amplification assays (to 9 targets)
with TaqManTM chemistry.
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79(POSTN; +3.0 SLR), cartilage linking protein 1 (CRTL-1;
+1.8  SLR),  dystrophin  (DMD;  +2.0  SLR),  Rho  GDP
dissociation inhibitor beta (ARHGDIB; +1.1 SLR), sulfatase
1 (SULF1; +1.1 SLR), thrombospondin-1 (THBS1;0.8 SLR),
and  bone  morphogenetic  protein-1  (BMP-1;  +0.7  SLR).
Among the 25 most down regulated genes in POAG were
Figure 3. Scatter plot matrices of the two
biologically  replicated  microarray
analyses.  Panel  A  shows  microarray
analysis 1. Panel B shows microarray
analysis 2. In each scatterplot the POAG
LC  cell  versus  normal  LC  cell
microarray  expression  data  following
normalization with RMA is shown. All
22,283  Log  base2  transformed  probe
(gene) signal intensities (range 0 - 14)
for the normal LC arrays are plotted on
the x-axes and the corresponding value
(range 0 - 14) for the POAG LC arrays
on the y-axes. For each probe (point), its
position relative to the diagonal identity
line  (red)  directly  relates  the  ratio  of
expression  in  POAG  versus  normal
control. Probes that appear above the
identity were overexpressed in POAG
LC  cells  (upregulated);  probes  that
appear  below  the  diagonal  were
overexpressed in the normal LC cells
(down regulated). Probes with identical
expression  levels  in  both  POAG  and
normal LC cells appear along or on the
identity line.
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80neuritin 1 (NRN1; −1.0 SLR) and prostaglandin D2 synthase
(PTGDS; −1.7 SLR). The ECM gene category, which was
significantly  overexpressed  in  POAG  versus  normal
contained 23 genes. These ECM genes are listed in Table 2.
The  proteins  of  these  ECM  genes  have  previously  been
documented in POAG in the lamina cribrosa, e.g., collagen
type I (COL1A1; +0.6 SLR), collagen type V (COL5A1; +0.5
SLR) and collagen type XI (COL11A1; +0.5 SLR). Notable
also  were  ECM  genes  or  ECM  modulating  genes  not
classically associated with POAG changes in the optic nerve
head such as tissue inhibitor of matrix metalloproteinase-3
(TIMP-3; +1.3 SLR), decorin (DCN; −0.9 SLR), versican
(VCAN;  +1.2  SLR),  lysyl  oxidase  (LOX;  +0.7  SLR),  and
secreted  acid  protein  cysteine  rich  (SPARC;  +1.1  SLR).
TABLE 1. FIFTY OF THE MOST UPREGULATED AND DOWN-REGULATED PROBE SETS (GENES) IN POAG LC CELLS VERSUS NORMAL LC CELLS.
PROBE ID GENE
Mean normal LC array
signal (n=2)




210809_s_at periostin 7.7 10.7 3.0
212951_at G protein-coupled receptor 116 4.5 6.9 2.5
203881_s_at dystrophin (muscular dystrophy, Duchenne and Becker types) 5.5 7.5 2.0
205523_at cartilage linking protein 1 4.7 6.5 1.8
203441_s_at cadherin 2, type 1, N-cadherin (neuronal) 6.2 7.8 1.6
201150_s_at tissue inhibitor of metalloproteinase 3 (TIMP-3) 7.3 8.6 1.3
206046_at a disintegrin and metalloproteinase domain 23 5.3 6.6 1.3
200974_at actin, alpha 2, smooth muscle, aorta 10.2 11.5 1.2
212572_at serine/threonine kinase 38 like 6.7 7.8 1.2
215646_s_at chondroitin sulfate proteoglycan 2 (versican) 7.3 8.4 1.2
202363_at sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 8.0 9.1 1.1
202620_s_at procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 6.9 8.0 1.1
201310_s_at chromosome 5 open reading frame 13 8.4 9.5 1.1
212354_at sulfatase 1 7.5 8.6 1.1
201288_at Rho GDP dissociation inhibitor (GDI) beta 5.8 6.9 1.1
203440_at cadherin 2, type 1, N-cadherin (neuronal) 8.0 9.0 1.0
211356_x_at leptin receptor 5.5 6.5 1.0
221011_s_at likely ortholog of mouse limb-bud and heart gene 6.8 7.7 0.9
210372_s_at tumor protein D52-like 1 7.8 8.7 0.9
218717_s_at myxoid liposarcoma associated protein 4 6.8 7.6 0.8
213869_x_at Thy-1 cell surface antigen 6.7 7.5 0.8
217853_at tensin-like SH2 domain-containing 1 6.8 7.6 0.8
201110_s_at thrombospondin 1 8.8 9.6 0.8
201109_s_at thrombospondin 1 9.8 10.5 0.8
205574_x_at bone morphogenetic protein 1 7.2 7.9 0.7
203540_at glial fibrillary acidic protein (GFAP) 4.0 4.0 0.0
212187_x_at prostaglandin D2 synthase 21 kDa (brain) 8.9 7.2 −1.7
213880_at G protein-coupled receptor 49 6.8 5.5 −1.3
209081_s_at collagen, type XVIII, alpha 1 7.5 6.1 −1.3
204897_at prostaglandin E receptor 4 (subtype EP4) 6.7 5.4 −1.3
212279_at hypothetical protein MAC30 7.3 6.0 −1.3
202437_s_at cytochrome P450, family 1, subfamily B, polypeptide 1 8.9 7.6 −1.3
217997_at pleckstrin homology-like domain, family A, member 1 6.6 5.3 −1.3
212386_at transcription factor 4 7.5 6.4 −1.1
209160_at aldo-keto reductase family 1, member C3 6.8 5.6 −1.3
215034_s_at transmembrane 4 superfamily member 1 8.8 7.6 −1.3
219064_at inter-alpha trypsin inhibitor heavy chain precursor 5 7.5 6.3 −1.2
206373_at Zic family member 1 (odd-paired homolog, Drosophila) 6.9 5.7 −1.2
214022_s_at interferon induced transmembrane protein 1 (9–27) 7.2 6.0 −1.2
201525_at apolipoprotein D 6.9 5.7 −1.1
212730_at desmuslin 7.2 6.1 −1.1
204249_s_at LIM domain only 2 (rhombotin-like 1) 6.5 5.1 −1.4
209466_x_at pleiotrophin 8.0 6.9 −1.1
202434_s_at cytochrome P450, family 1, subfamily B, polypeptide 1 6.7 5.6 −1.0
213891_s_at transcription factor 4 7.2 6.2 −1.0
218625_at neuritin 1 7.1 6.2 −1.0
208791_at clusterin 8.0 7.1 −0.9
202075_s_at phospholipid transfer protein 6.9 6.0 −0.9
209335_at decorin 7.7 6.9 −0.9
204987_at inter-alpha (globulin) inhibitor, H2 polypeptide 6.2 5.4 −0.9
212992_at chromosome 14 open reading frame 78 7.9 7.2 −0.8
Leftmost column: Affymetrix probe IDs; center column: gene names; right most columns: RMA normalized gene signal
intensities for normal (n=2) and POAG (n=2) and calculated signal log ratio changes for each gene. Probe IDs were annotated
by uploading tab delimited *.txt files of the IDs and signal log ratios to the NIH DAVID software website as described in the
Methods section. Genes in bold were validated by real time PCR. Confirmation of the GFAP-negativity of the normal and POAG
LC cells is shown by low signal levels for GFAP.
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81Validation of the characterization of our LC cells as GFAP-
negative was demonstrated by very low signal detection (less
than 6.5) for GFAP in both of the normal (mean signal 4.0)
and POAG (mean signal 4.0) microarrays (see Table 1).
Validation  of  POAG  versus  normal  LC  cell  microarray
analysis using quantitative real time PCR: To validate the
normal versus POAG expression patterns obtained from the
microarray analyses we investigated the expression of 9 genes
using  quantitative  real  time  PCR.  Given  that  microarray
experiments yield large amounts of data we focused our real
time PCR analyses on a sample of targets that were members
of the most up or down regulated genes or were members of
the ECM category. The validated upregulated targets were:
periostin (POSTN; 35 fold, *p=0.008), Rho GDP dissociation
inhibitor  beta  (ARHGDIB;  4.5  fold,  *p=0.02),  cartilage
linking protein 1 (CRTL-1; 240 fold, *p=0.003), dystrophin
(DMD; 3.2 fold, *p=0.0005), sulfatase 1 (SULF1; 8 fold,
*p=0.006),  thrombospondin-1  (THBS1;  1.7  fold,  *p=0.02)
and  bone  morphogenetic  protein-1  (BMP-1;  2.0  fold,
*p=0.02). The validated down regulated targets were neuritin
1 (NRN1; 60 fold, *p=0.02) and prostaglandin D2 synthase
(PTGDS; 22 fold, *p=0.02). Table 3 illustrates the results of
these  analyses  with  the  corresponding  microarray  fold
expression  changes  determined  for  each  gene.  All  targets
assayed  by  real  time  PCR  showed  a  significant  change
(*p<0.05) which was consistent with the direction of change
identified by the microarray analysis.
Immunoflourescence  histochemistry:  Periostin  (POSTN;
green) immunoreactivity was increased in the lamina cribrosa
of  glaucomatous  optic  nerve  tissue  sections  (Figure  4B)
compared with the normal control sections (Figure 4A). A
representative micrograph is shown in Figure 4. No staining
was evident when the primary antibody was omitted (Figure
4C,D).
DISCUSSION
This  study  investigated  the  transcriptional  differences
between  normal  and  POAG  LC  cells  which  we  believe
contributes substantially to current understanding of ECM
remodeling mechanisms in the lamina cribrosa in POAG. We
have established for the first time, a baseline transcription
differential between the normal and diseased state GFAP-
negative LC cell, in terms of both genome-wide and ECM
expression. In addition, our objective was to identify whether
this transcription differential between POAG and normal LC
cells was pro-fibrotic, further supporting the paradigm that LC
cells contribute to ECM remodeling in POAG.
TABLE 2. EXTRACELLULAR MATRIX (ECM) PROBE SETS (GENES) THAT WERE DIFFERENTIALLY EXPRESSED IN POAG LC CELLS VERSUS NORMAL LC
CELLS.
PROBE ID GENE
Mean normal LC array
signal (n=2)




210809_s_at osteoblast specific factor 2 (periostin) 7.7 10.7 3.0
203881_s_at dystrophin 5.5 7.5 2.0
205524_s_at cartilage linking protein 1 4.7 6.5 1.8
201150_s_at tissue inhibitor of metalloproteinase 3 (TIMP-3) 7.3 8.6 1.3
215646_s_at chondroitin sulfate proteoglycan 2 (versican) 7.3 8.4 1.2
202363_at
sparc/osteonectin, cwcv and kazal-like domains
proteoglycan 8.0 9.1 1.1
211571_s_at chondroitin sulfate proteoglycan 2 (versican) 7.8 8.8 1.1
201110_s_at thrombospondin 1 8.8 9.6 0.8
204298_s_at lysyl oxidase 9.5 10.2 0.7
201842_s_at
EGF-containing fibulin-like extracellular matrix
protein 1 9.8 10.4 0.6
201506_at transforming growth factor, beta-induced, 68 kDa 11.1 11.7 0.6
202311_s_at collagen, type I, alpha 1 8.7 9.2 0.6
212667_at secreted protein, acidic, cysteine-rich (osteonectin) 10.1 10.6 0.6
212488_at collagen, type V, alpha 1 9.6 10.1 0.5
209278_s_at tissue factor pathway inhibitor 2 6.9 7.4 0.5
204320_at collagen, type XI, alpha 1 6.8 7.3 0.5
205200_at tetranectin (plasminogen binding protein) 9.1 7.6 −1.4
209081_s_at collagen, type XVIII, alpha 1 7.5 6.1 −1.3
203886_s_at fibulin 2 8.1 7.1 −1.0
211343_s_at collagen, type XIII, alpha 1 5.7 4.8 −1.0
209335_at decorin 7.7 6.9 −0.9
202995_s_at fibulin 1 6.2 5.5 −0.7
212713_at microfibrillar-associated protein 4 7.2 6.5 −0.7
The individual member genes of the functional family of ECM was annotated in the table above using NIH DAVID software
and it lists ECM genes which were up or down regulated by ± 0.5 SLR or greater in POAG LC cells versus normal LC cells.
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82In the global gene expression comparison, we identified
403 genes that were reliably differentially expressed in POAG
LC cells compared to normal LC cells by greater than ±0.5
signal log ratios with RMA signal intensities of greater than
6.5. EASE analysis further identified that three functional
gene categories of ECM, extracellular space and collagen
were among the most significantly (*p<0.05) overexpressed
categories within this 403-gene data set (Appendix 1). The
disease progression of POAG involves not only fibrotic ECM
remodeling  of  the  lamina  cribrosa,  but  other  pathological
phenomena such as reduced optic nerve head blood flow,
retinal  ganglion  cell  axon  death  and  transcriptional
reactivation of developmentally regulated genes [20-22]. The
top 50 most differentially expressed genes in POAG LC cells
compared  with  normals,  reflected  this  multi-mechanistic
pathology by containing an interesting combination of ECM,
cytoskeletal, angiogenic, neuronal and developmental genes.
These  included  thrombospondin-1  (THBS1),  prostaglandin
D2  synthase  (PTGDS),  sulfatase  1  (SULF1),  pleiotrophin
(NEGF1),  neuritin  1  (NRN1),  N-cadherin  (NCAD),  bone
morphogenetic protein-1 (BMP-1), and zic family member 1
(ZIC1; Table 1). In addition, by demonstrating low probe
signal levels (below 6.5) for GFAP in both normal and POAG
LC cells (Table 1), our microarray output provides further
evidence that LC cells are distinguishable from the GFAP-
positive optic nerve head astrocyte population of the lamina
cribrosa.
Thrombospondin-1 (THBS1; upregulated in POAG LC
cells) is a major activator of extracellular transforming growth
factor beta 1 (TGFβ1) in fibrotic renal disease in the rat and
is  closely  involved  in  angiogenesis  in  hepatocellular
carcinoma  [23,24].  Prostaglandin  D2  synthase  (PTGDS;
down regulated in POAG LC cells) has an antihypoxic effect
in  mice  [25]  which  together  with  thrombospondin-1
upregulation was intriguing in the context of hypoxic insult
and vascular hypoperfusion of the optic nerve head in POAG.
Sulfatase 1 (SULF1) has been shown as an early marker of
glial cell precursors [26] and its upregulation in POAG LC
cells suggests consistency with the hypothesis that wound
formation  and  healing  involves  the  recapitulation  of
embryonic  gene  expression.  Pleiotrophin  (NEGF1)  down
regulation and neuritin 1 (NRN1) upregulation in POAG LC
cells was also interesting in terms of axon death in POAG as
the primary function of these genes are in neuritogenesis [27,
28]. N-cadherin (NCAD) which was upregulated in POAG LC
cells, is involved in synaptic adhesion in the CNS and is
transcriptionally  regulated  by  TGFβ  [29,30].  Bone
morphogenetic protein-1 (BMP-1) and zic family member 1
(ZIC1), two other developmental genes, play roles in ECM
synthesis and CNS development, respectively [31,32].
The results of EASE analysis clearly stated that ECM was
a  significant  gene  family  difference  between  normal  and
POAG LC cells. A total of 23 ECM genes were differentially
expressed by greater than +/−0.5 SLR in POAG versus normal
LC cells (Table 1). This provided transcriptional evidence that
the  LC  cell  may  be  a  source  of  fibrotic  ECM  protein
production in the glaucomatous lamina cribrosa, particularly
as  this  collection  of  genes  contained  the  classic  fibrotic
marker,  collagen  type  I  [33-35].  Others,  which  included
cartilage linking protein 1 (CRTL-1), periostin (POSTN), and
dystrophin (DMD), are novel in the context of optic nerve head
remodeling in POAG.
Our finding that periostin (POSTN) was upregulated at
the mRNA level in POAG LC cells and at the protein level in
TABLE 3. VALIDATION OF THE MICROARRAY EXPRESSION PATTERNS OF POAG VERSUS NORMAL LC CELLS BY REAL TIME
QUANTITATIVE PCR.
Gene Microarray analysis Real time PCR
Upregulated in POAG Mean fold change (n=2) Mean fold change (n=3)
periostin 8 35 (*p=0.008)
cartilage linking protein-1 3.5 240 (*p=0.003)
dystrophin 4 3.2 (*p=0.0005)
sulfatase-1 2 8 (*p=0.006)
rho GDP dissociation inhibitor beta 2 4.5 (*p=0.02)
thrombospondin-1 1.7 1.7 (*p=0.02)
BMP-1 1.6 2 (*p=0.02)
Downregulated in POAG Mean fold change (n=2) Mean fold change (n=3)
neuritin-1 2 60 (*p=002)
prostaglandin D2 synthase 3.2 22 (*p=0.02)
Columns show the gene name, the fold expression change (converted from signal log ratio (SLR) using the formula: fold
change=2(signal log ratio)) determined by microarray and the corresponding expression change determined by real time PCR. Results
for real time PCR are shown in bold and are expressed as the mean of three separate experiments (n=3) with the calculated p
value, where *p<0.05 was considered to be statistically significant.
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83optic nerve head tissue was interesting in that this gene is
regulated by hypoxia responsive growth factors (e.g., FGF-1)
and is thought to be one of the main genes involved in ECM
tissue  remodeling  following  mechanical  stress  in  rat
pulmonary arterial smooth muscle cells and human cardiac
myocytes [36-38]. This demonstrates consistency with the
established mechanical and vascular theories of optic nerve
damage in POAG. Furthermore, our data are consistent with
that of a previous animal model study which demonstrated a
linear increase in optic nerve head tissue periostin (POSTN)
mRNA expression in response to elevated IOP [39].
Cartilage  linking  protein  1  (CRTL-1)  which  was  also
upregulated  in  POAG  LC  cells,  stabilizes  the  interaction
between hyaluronan and the ECM [40]. Hyaluronans provide
connective  tissues  with  mechanical  resilience  and  are
important  components  of  the  human  lamina  cribrosa  [5].
Upregulation  of  CRTL-1  may  represent  an  attempt  to
mechanically re-inforce the lamina cribrosa against rising IOP
or inhibit falling hyaluronan levels which have also been
shown in POAG optic nerve heads [41]. Dystrophin (DMD)
upregulation in POAG LC cells may also bear relevance to
transduction  of  mechanical  stimuli  in  raised  IOP,  as  the
protein of this gene forms links between the ECM and the
cytoskeleton  [42].  Tissue  inhibitor  of  matrix
metalloproteinase-3  (TIMP-3)  is  a  member  of  the  tissue
inhibitor of matrix metalloproteinase family (TIMPs). The
protein  of  this  gene  specifically  inhibits  several  ECM
degrading  enzymes  including  matrix  metalloproteinase-2
(MMP-2) [43]. The substrates for MMP-2 include elastin and
collagen type IV [44]. Upregulated expression of TIMP-3 in
our POAG LC cells is, therefore, consistent with the overall
increase in collagen type IV (COL4A1) and elastin that is
observed in the lamina cribrosa in POAG. Decorin down
regulation in our POAG LC cells may also be of significance
to  loss  of  lamina  cribrosa  architecture  in  POAG.  It  co-
localizes  with  collagen  type  I  (COL1A1)  in  the  ECM
modulating collagen fiber spacing and assembly [45].
Transforming growth factor beta induced (TGFβI), was
another upregulated ECM gene in our POAG LC cells that
plays  a  role  in  collagen  metabolism.  We  have  previously
shown that TGFβI is a transforming growth factor beta-1
(TGFβ-1) inducible gene in LC cells [13]. The protein of this
gene binds and promotes aggregation of collagen type VI
(COL6A1) and mediates cell-collagen interactions in the ECM
Figure  4.  Representative
immunofluorescence histochemistry of
normal and glaucomatous human optic
nerve  head  lamina  cribrosa  tissue.
Normal (A) and glaucomatous (B) optic
nerve  head  sections  were  stained  for
Periostin  (green).  Periostin  was
increased  in  the  lamina  cribrosa  of
glaucomatous sections compared to the
normal  controls.  No  immunostaining
was  seen  in  the  absence  of  primary
antibody (C and D shows blue DAPI
staining of nuclei).
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84[46]. Since type VI collagen is a major component of the
lamina cribrosa, TGFβI overexpression in POAG LC cells
may explain the accumulation of type VI collagen in the
glaucomatous lamina cribrosa. Other noteworthy upregulated
ECM genes in POAG LC cells in our study included versican
(VCAN) whose protein is synonymous with the fibroblastic
phenotype [47,48]. In addition, the ECM-related gene lysyl
oxidase (LOX), which initiates the cross linking of collagen
and elastin was also upregulated in our system. Interestingly,
another  member  of  this  gene  family  lysyl  oxidase-like  1
(LOXL1) has been found to contain two single nucleotide
polymorphisms  (SNPs)  in  patients  who  develop
pseudoexfoliation glaucoma [49].
In  summary,  this  work  has  identified  a  baseline
transcriptional differential between GFAP-negative LC cells
from  normal  and  POAG  human  donors  in-vitro.  This
transcriptional  differential  is  strikingly  defined  by  pro-
fibrotic/ECM  genes,  which  we  believe  are  pathologically
characteristic of POAG LC cells in-vivo. The data, therefore,
underlines  the  strong  potential  role  for  LC  cells  in
glaucomatous optic nerve head ECM remodeling. POAG LC
cells may also possess an ab-initio inevitability to express
fibrotic/ECM genes following exposure to other pathological
stimuli in POAG such as mechanical strain or hypoxic stress.
In conclusion, this analysis provides a framework upon which
to  base  further  pathway-specific  and  LC  cell-targeted
investigations  of  the  discrete  mechanisms  that  dictate  the
evolution of optic nerve head ECM remodeling in POAG.
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87Appendix 1. Ontology of up and down regulated genes in POAG LC cells
versus normal LC cells.
Table A lists the ontological categories (biologic process,
cellular component, molecular function) generated from the
upregulated genes in POAG versus normal LC cells. Table B
lists  the  ontological  categories  generated  from  the  down
regulated  genes  in  POAG  versus  normal  LC  cells.  The
significantly  overexpressed  functional  groups  are  shown.
EASE scores (Pvalue) are indicated next to each functional
group.  EASE  scores  less  than  0.05  were  considered
statistically significant. To access the data, click or select the
words “Appendix 1.” This will initiate the download of a
compressed (pdf) archive that contains the file.
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